Company Number: 13514918

Analysis Date: 2025-07-20 18:18 UTC

Financial Health Score: B-

SRI GROUP LIMITED shows a stable but modest financial position typical of a micro-entity in its early years. The company has maintained positive net assets and working capital, indicating a "healthy cash flow" at a basic level, but the scale and growth are limited, which suggests early-stage development with some constraints.

---

Key Vital Signs

Metric	2024	2023	Interpretation
Current Assets	£7,725	£1,711	Growing short-term resources indicate improving liquidity.
Net Current Assets (Working Capital)	£7,725	£1,711	Positive working capital shows ability to cover short-term liabilities.
Net Assets (Equity)	£7,525	£1,511	Increasing equity suggests retained earnings or capital injection, a sign of strengthening financial foundation.
Director Loan Advances	£4,500	N/A	Interest-free loans to director show internal financing but also tied-up funds.
Employees	1	1	Minimal staff, reflecting micro-entity status and limited operational scale.

---

Symptoms Analysis

• Liquidity: The company has maintained positive net current assets each year, indicating no immediate liquidity distress. The increase from £1,711 to £7,725 signifies improved short-term financial health, which is like a "healthy pulse" in financial terms.
• Capital Structure: Net assets are positive and growing, from £1,511 to £7,525, reflecting either retained profits or additional capital contributions. This is a "good blood pressure," showing the company is not over-leveraged.
• Operational Scale: With only one employee and micro-entity classification, the business remains very small with limited operational complexity.
• Financial Support: The director’s interest-free loan of £4,500 provides additional liquidity but also indicates reliance on internal funding rather than external financing.
• Financial Reporting: The accounts are prepared under the micro-entity regime, which limits disclosure but is suitable for the company size.

---

Diagnosis

SRI GROUP LIMITED is financially stable but in the nascent stage of its development. The company’s financial "vital signs" indicate no acute distress: liquidity and equity positions are positive and improving. However, the small scale and minimal resources suggest limited operational capacity and growth potential at this point. The director’s loan, while interest-free, represents a mild "symptom" of internal funding reliance, which may need addressing if the business seeks expansion or external investment.

---

Prognosis

If the company can maintain or accelerate asset growth and improve profitability, its financial health should strengthen, potentially moving towards a higher grade with more robust equity and liquidity. However, dependence on internal loans and a very small employee base may constrain growth unless addressed. Monitoring cash flow, increasing operational capacity, and exploring external funding or revenue growth will be critical to improving financial vitality.

---

Recommendations

1. Enhance Revenue Growth: Focus on expanding business operations beyond the micro scale to improve cash inflows and profitability.
2. Strengthen Working Capital Management: Maintain or improve liquidity buffers to safeguard against unexpected expenses.
3. Reduce Reliance on Director Loans: Consider formal financing routes or capital injections to reduce financial dependence on internal loans.
4. Improve Financial Reporting: As the company grows, consider moving beyond micro-entity reporting for greater transparency, which can attract investors or lenders.
5. Plan for Staff Growth: Evaluate operational needs and consider hiring additional employees to support business scaling.
6. Regular Financial Review: Conduct periodic financial health checks to catch early signs of distress and adjust business strategies accordingly.

---